BCYC logo

Bicycle Therapeutics (BCYC) Cash From Investing

Annual CFI

-$2.93 M
+$16.06 M+84.57%

December 31, 2023

Summary

Performance

1-Year Change

+84.57%

3-Year Change

-144.08%

5-Year Change

-146.96%

15-Year Change

-163.16%

BCYC Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

38.9%
BCYC annual cash flow from investing activities is higher than 38.9% of companies in Healthcare sector

High & Low

All-time High

-$1.11 M

3-Year Low

-$18.99 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
BCYC previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 20, 2025
BCYC next annual earnings announcement is scheduled for Feb 20, 2025

OtherBCYCcash flowmetrics:

Annual CFF

$250.03 M
BCYC annual cash flow from financing activities is $250.03 million

Annual CFO

-$60.63 M
BCYC annual cash flow from operations is -$60.63 million

Annual FCF

-$63.56 M
BCYC annual free cash flow is -$63.56 million

Annual CAPEX

$2.93 M
BCYC annual capital expenditures is $2.93 million

Quarterly CFI

-$435.00 K
-$15.00 K-3.57%

September 30, 2024

Summary

Performance

3-Month Change

-3.57%

1-Year Change

-3.57%

3-Year Change

-3.57%

5-Year Change

-3.57%

BCYC Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.51%
BCYC quarterly cash flow from investing activities is higher than 37.51% of companies in Healthcare sector

High & Low

All-time High

-$12.00 K

3-Year Low

-$9.80 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BCYC previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 20, 2025
BCYC next earnings announcement is scheduled for Feb 20, 2025

OtherBCYCcash flowmetrics:

Quarterly CFF

-$31.93 M
BCYC quarterly cash flow from financing activities is -$31.93 million

Quarterly CFO

-$39.83 M
BCYC quarterly cash flow from operations is -$39.83 million

Quarterly FCF

-$40.27 M
BCYC quarterly free cash flow is -$40.27 million

Quarterly CAPEX

$435.00 K
BCYC quarterly capital expenditures is $435.00 thousand

TTM CFI

-$918.00 K
+$67.00 K+6.80%

September 30, 2024

Summary

Performance

3-Month Change

+6.8%

1-Year Change

+6.8%

3-Year Change

+6.8%

5-Year Change

+6.8%

BCYC TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

45.38%
BCYC TTM cash flow from investing activities is higher than 45.38% of companies in Healthcare sector

High & Low

All-time High

-$264.00 K

3-Year Low

-$18.99 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BCYC previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 20, 2025
BCYC next earnings announcement is scheduled for Feb 20, 2025

OtherBCYCcash flowmetrics:

TTM CFF

$519.93 M
BCYC TTM cash flow from financing activities is $519.93 million

TTM CFO

-$202.62 M
BCYC TTM cash flow from operations is -$202.62 million

TTM FCF

-$203.53 M
BCYC TTM free cash flow is -$203.53 million

TTM CAPEX

$918.00 K
BCYC TTM capital expenditures is $918.00 thousand

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BCYC Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+84.6%-3.6%+6.8%
3 y3 years-144.1%-3.6%+6.8%
5 y5 years-147.0%-3.6%+6.8%

BCYC Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-44.3%+84.6%-3525.0%+95.6%-9.0%+95.2%
5 y5-year-144.1%+84.6%-3525.0%+95.6%-9.0%+95.2%
alltimeall time-163.2%+84.6%-3525.0%+95.6%-247.7%+95.2%

Bicycle Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$435.00 K(+3.6%)
-$918.00 K(-6.8%)
Jun 2024
-
-$420.00 K(+3400.0%)
-$985.00 K(+17.0%)
Mar 2024
-
-$12.00 K(-76.5%)
-$842.00 K(-71.3%)
Dec 2023
-$2.93 M(-84.6%)
-$51.00 K(-89.8%)
-$2.93 M(-32.3%)
Sep 2023
-
-$502.00 K(+81.2%)
-$4.33 M(-36.5%)
Jun 2023
-
-$277.00 K(-86.8%)
-$6.81 M(-58.3%)
Mar 2023
-
-$2.10 M(+45.0%)
-$16.33 M(-14.0%)
Dec 2022
-$18.99 M(+835.3%)
-$1.45 M(-51.5%)
-$18.99 M(+2.0%)
Sep 2022
-
-$2.98 M(-69.5%)
-$18.61 M(+17.8%)
Jun 2022
-
-$9.80 M(+106.0%)
-$15.79 M(+156.2%)
Mar 2022
-
-$4.76 M(+345.7%)
-$6.16 M(+203.6%)
Dec 2021
-$2.03 M
-$1.07 M(+531.4%)
-$2.03 M(+40.3%)
Sep 2021
-
-$169.00 K(-1.2%)
-$1.45 M(+5.4%)
Jun 2021
-
-$171.00 K(-72.6%)
-$1.37 M(-8.6%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$623.00 K(+28.7%)
-$1.50 M(+25.3%)
Dec 2020
-$1.20 M(-22.8%)
-$484.00 K(+409.5%)
-$1.20 M(+8.4%)
Sep 2020
-
-$95.00 K(-68.4%)
-$1.11 M(-14.5%)
Jun 2020
-
-$301.00 K(-5.9%)
-$1.29 M(-11.1%)
Mar 2020
-
-$320.00 K(-18.2%)
-$1.46 M(-6.3%)
Dec 2019
-$1.55 M(+31.1%)
-$391.00 K(+38.2%)
-$1.55 M(-1.2%)
Sep 2019
-
-$283.00 K(-38.9%)
-$1.57 M(+11.1%)
Jun 2019
-
-$463.00 K(+10.8%)
-$1.42 M(+5.7%)
Mar 2019
-
-$418.00 K(+2.0%)
-$1.34 M(+13.0%)
Dec 2018
-$1.19 M(+6.6%)
-$410.00 K(+225.4%)
-$1.19 M(+52.8%)
Sep 2018
-
-$126.00 K(-67.4%)
-$776.00 K(+19.4%)
Jun 2018
-
-$386.00 K(+46.2%)
-$650.00 K(+146.2%)
Mar 2018
-
-$264.00 K
-$264.00 K
Dec 2017
-$1.11 M
-
-

FAQ

  • What is Bicycle Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Bicycle Therapeutics?
  • What is Bicycle Therapeutics annual CFI year-on-year change?
  • What is Bicycle Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Bicycle Therapeutics?
  • What is Bicycle Therapeutics quarterly CFI year-on-year change?
  • What is Bicycle Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Bicycle Therapeutics?
  • What is Bicycle Therapeutics TTM CFI year-on-year change?

What is Bicycle Therapeutics annual cash flow from investing activities?

The current annual CFI of BCYC is -$2.93 M

What is the all time high annual CFI for Bicycle Therapeutics?

Bicycle Therapeutics all-time high annual cash flow from investing activities is -$1.11 M

What is Bicycle Therapeutics annual CFI year-on-year change?

Over the past year, BCYC annual cash flow from investing activities has changed by +$16.06 M (+84.57%)

What is Bicycle Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of BCYC is -$435.00 K

What is the all time high quarterly CFI for Bicycle Therapeutics?

Bicycle Therapeutics all-time high quarterly cash flow from investing activities is -$12.00 K

What is Bicycle Therapeutics quarterly CFI year-on-year change?

Over the past year, BCYC quarterly cash flow from investing activities has changed by -$15.00 K (-3.57%)

What is Bicycle Therapeutics TTM cash flow from investing activities?

The current TTM CFI of BCYC is -$918.00 K

What is the all time high TTM CFI for Bicycle Therapeutics?

Bicycle Therapeutics all-time high TTM cash flow from investing activities is -$264.00 K

What is Bicycle Therapeutics TTM CFI year-on-year change?

Over the past year, BCYC TTM cash flow from investing activities has changed by +$67.00 K (+6.80%)